Trials / Unknown
UnknownNCT04921293
Comparison Between Endogenous and Exogenous Ketosis in Patients With Non-ischemic Chronic Heart Failure With Reduced Ejection Fraction
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This randomized controlled trial will evaluate the effect of a ketogenic diet and/or exogenous administration of ketone bodies vs conventional diet on the ejection fraction of patients with non-ischemic chronic heart failure, measuring MRI biomarkers.
Detailed description
Evidence in both animals and humans suggests ketosis could be beneficial for people living with chronic heart failure. To date, no study has compared endogenous vs exogenous ketosis in patients with chronic heart failure. We will randomize (with a 1:1:1 ratio) patients with a confirmed diagnosis of non-ischemic chronic heart failure to undergo one of the following: 1. \- A ketogenic diet (\<50 gr of carbohydrates per day) incorporating current recommendations for heart failure (low sodium and liquids) for 10 days. 2. \- Standard diet incorporating current recommendations for heart failure (low sodium and liquids) and supplementation with exogenous ketones (ketone monoester) for 10 days. 3. \- Standard diet incorporating current recommendations for heart failure (low sodium and liquids) and supplementation with bitter taste placebo. The endpoints will be assessed using cardiac MRI and blood biomarkers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Ketogenic diet | A diet with \<50gr of carbohydrates per day. Monosaturated fats consumption will encourage over saturated fats |
| DIETARY_SUPPLEMENT | Exogenous ketones | Administration of ketone monoester 25 ml t.i.d |
| BEHAVIORAL | Standard diet + placebo | A standard diet incorporating current recommendations (low in sodium and low in liquids) for heart failure patients. |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2024-10-20
- Completion
- 2024-12-01
- First posted
- 2021-06-10
- Last updated
- 2022-10-18
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04921293. Inclusion in this directory is not an endorsement.